Pages that link to "Q46774355"

The following pages link to Active antitoxic immunization by a diphtheria toxin synthetic oligopeptide (Q46774355):

Displaying 46 items.

• Immunogenicity of overlapping synthetic peptides covering the entire sequence of Haemophilus influenzae type b outer membrane protein P2. (Q33601007) (← links)
• A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b. (Q33756634) (← links)
• An antibody to a synthetic peptide that recognises SV40 small-t antigen (Q33927959) (← links)
• Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA. (Q34001579) (← links)
• Prediction of sequential antigenic regions in proteins (Q34377036) (← links)
• New hepatitis B vaccines (Q34490083) (← links)
• Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles (Q35373888) (← links)
• Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1. (Q35440720) (← links)
• Antibodies specific for the polyoma virus middle-size tumor antigen (Q35458911) (← links)
• Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. (Q35772798) (← links)
• Purification of polyoma virus medium-size tumor antigen by immunoaffinity chromatography (Q36301658) (← links)
• Successful immunization with a totally synthetic diphtheria vaccine (Q36308543) (← links)
• Immunofluorescent localization of the transforming protein of Rous sarcoma virus with antibodies against a synthetic src peptide (Q36310517) (← links)
• Immunological castration of male mice by a totally synthetic vaccine administered in saline (Q36311031) (← links)
• On the nature of crossreactions observed with antibodies directed to defined epitopes. (Q36314222) (← links)
• Human antibody response to fragments A and B of diphtheria toxin and a synthetic peptide of amino acid residues 141-157 of fragment A (Q36505082) (← links)
• Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier (Q37020185) (← links)
• Peptide antibody specific for the amino terminus of skeletal muscle alpha-actin (Q37605968) (← links)
• Analysis of an evolutionarily conserved antigenic site on mammalian cytochrome c using synthetic peptides (Q37679665) (← links)
• Antibodies against synthetic peptides of the B subunit of cholera toxin: crossreaction and neutralization of the toxin (Q37690884) (← links)
• Synthetic T and B cell recognition sites: implications for vaccine development (Q38665396) (← links)
• Towards a Recombinant Vaccine against Diphtheria Toxin (Q39569810) (← links)
• Current trends and advances in bacterial vaccines today (Q39764904) (← links)
• Scope of DNA cloning and chemical methods in development of chemotherapeutic agents (Q40076283) (← links)
• Antibodies of Predetermined Specificity in Biology and Medicine (Q40112366) (← links)
• Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity (Q40158183) (← links)
• Muramyl Peptides as Possible Endogenous Immunopharmacological Mediators (Q40164050) (← links)
• Muramyl peptides: Immunomodulators, sleep factors, and vitamins (Q40178426) (← links)
• A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1 (Q41464907) (← links)
• Expression and purification of truncated diphtheria toxin, DT386, in Escherichia coli: An attempt for production of a new vaccine against diphtheria (Q41870925) (← links)
• Monoclonal B-cell response to diphtheria toxoid: evidence for cross-reactive epitopes (Q42638332) (← links)
• Antibodies That React with Predetermined Sites on Proteins (Q43560329) (← links)
• Immune response to diphtheria toxin and to different CNBr fragments: evidence for different B and T cell reactivities (Q44296959) (← links)
• Monoclonal antibody analysis of diphtheria toxin—I. Localization of epitopes and neutralization of cytotoxicity (Q44949165) (← links)
• New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP. (Q54474084) (← links)
• Synthetic Antigens and Vaccines (Q58352976) (← links)
• Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein (Q59097467) (← links)
• Genetic engineering and pharmaceuticals (Q64517808) (← links)
• Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) fromBordetella pertussis (Q67690195) (← links)
• [Anti-toxin vaccines] (Q69931764) (← links)
• Developing synthetic vaccines (Q70276041) (← links)
• Use of antibodies against synthetic peptides for analysis of molecular multiplicity: human deoxyribonuclease I polymorphism (Q71632715) (← links)
• Physicochemical and antigenic properties of synthetic fragments of human leukocyte interferon (Q72650571) (← links)
• Synthetic peptides as the basis for future vaccines (Q72668724) (← links)
• Epitope specific immunity elicited by a synthetic streptococcal antigen without carrier or adjuvant (Q72721836) (← links)
• Development and application of synthetic peptides as vaccines (Q79145670) (← links)